Showing results (3101-3110 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|August 6, 2021
Next-Generation Sequencing in the Diagnosis of Metastatic Lesions: Reclassification of a Glioblastoma as an Endometrial Cancer Metastasis to the BrainShuk On Annie Leung, Olivia Foley, David Chapel, et al.
The Oncologist|May 18, 2021
Succinate Dehydrogenase-Deficient Renal Cancer Featuring Fructose-1,6-Biphosphatase Loss, Pyruvate Kinase M2 Overexpression, and SWI/SNF Chromatin Remodeling Complex Aberrations: A Rare Case ReportMichal Szymanski, Natalia Rusetska, Iga Jancewicz, et al.
The Oncologist|August 2, 2022
Targeting CDK4 and 6 in Cancer Therapy: Emerging Preclinical Insights Related to AbemaciclibSeth A Wander, Neil O'Brien, Lacey M Litchfield, et al.
The Oncologist|August 3, 2022
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO NetworkPasquale Rescigno, Marco Maruzzo, Sara Elena Rebuzzi, et al.
The Oncologist|August 13, 2022
Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor BoardMichelle F Green, Catherine H Watson, Sarah Tait, et al.
The Oncologist|April 10, 2020
The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of ToxicitiesLaura J Klesse, Justin T Jordan, Heather B Radtke, et al.
The Oncologist|April 10, 2020
The Predictive Value of Early Changes in 18 F-Fluoroestradiol Positron Emission Tomography/Computed Tomography During Fulvestrant 500 mg Therapy in Patients with Estrogen Receptor-Positive Metastatic Breast CancerMin He, Cheng Liu, Qin Shi, et al.
The Oncologist|April 10, 2020
FDA Accelerated Approval of Pembrolizumab for Recurrent Locally Advanced or Metastatic Merkel Cell CarcinomaDiana Bradford, Suzanne Demko, Susan Jin, et al.
The Oncologist|May 21, 2021
A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline MutationKelsey T Danley, Karen Schmitz, Ritu Ghai, et al.
The Oncologist|April 30, 2021
Designation Products: Boron Neutron Capture Therapy for Head and Neck CarcinomaHitoshi Kanno, Hironori Nagata, Akihiro Ishiguro, et al.
Pageof 571